Additionally, many studies indicate that ENPP1 is highly expressed in many cancers, including lung cancer (16), ovarian cancer (17) and breast cancer (18), and that this overexpression is a strong indicator of poor prognosis in different cancers. Here, ENPP1 is linked to lung carcinoma.